|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 112, Issue 13 2223-2232, Copyright © 1999 by Company of Biologists
JOURNAL ARTICLES |
K Rothbarth, E Spiess, B Juodka, U Yavuzer, P Nehls, H Stammer and D Werner
Division Biochemistry of the Cell and Biomedical Structure Analysis Group, German Cancer Research Center, D-69120 Heidelberg, Germany.
Apoptosis is induced in various tumor cell lines by vector-dependent overexpression of the conserved gene C1D that encodes a DNA-binding and DNA-PK-activating protein. C1D is physiologically expressed in 50 human tissues tested, which points to its basic cellular function. The expression of this gene must be tightly regulated because elevated levels of C1D protein, e.g. those induced by transient vector-dependent expression, result in apoptotic cell death. Cells transfected with C1D-expressing constructs show terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling of DNA ends. Transfections with constructs in which C1D is expressed in fusion with the (enhanced) green fluorescent protein from A. victoria (EGFP) allow the transfected cells to be identified and the morphological changes induced to be traced. Starting from intense nuclear spots, green fluorescence reflecting C1D expression increases dramatically at 12-24 hours post-transfection. Expression of C1D-EGFP protein is accompanied by morphological changes typical of apoptotic cell death, e.g. cytoplasmic vacuolation, membrane blebbing and nuclear disintegration. Cell shrinkage and detachment from extracellular matrix are observed in monolayer cultures while suspension cells become progressively flattened. The facility to differentiate between transfected and non-transfected cells reveals that non-transfected cells co-cultured with transfected cells also show the morphological changes of apoptosis, which points to a bystander effect. C1D-dependent apoptosis is not induced in cells with non-functional p53. Accordingly, C1D-induced apoptosis is discussed in relation to its potential to activate DNA-PK, which has been considered to act as an upstream activator of p53.
This article has been cited by other articles:
|
|
 |
|
  C.-N. Sun, H.-C. Cheng, J.-l. Chou, S.-Y. Lee, Y.-W. Lin, H.-L. Lai, H.-M. Chen, and Y. Chern Rescue of p53 Blockage by the A2A Adenosine Receptor via a Novel Interacting Protein, Translin-Associated Protein X Mol. Pharmacol., August 1, 2006; 70(2): 454 - 466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gupta and K. Meek The leucine rich region of DNA-PKcs contributes to its innate DNA affinity Nucleic Acids Res., December 9, 2005; 33(22): 6972 - 6981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Dip and H. Naegeli More than just strand breaks: the recognition of structural DNA discontinuities by DNA-dependent protein kinase catalytic subunit FASEB J, May 1, 2005; 19(7): 704 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Sakashita, S. Tatsumi, D. Werner, H. Endo, and A. Mayeda Human RNPS1 and Its Associated Factors: a Versatile Alternative Pre-mRNA Splicing Regulator In Vivo Mol. Cell. Biol., February 1, 2004; 24(3): 1174 - 1187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Erdemir, B. Bilican, D. Oncel, C. R. Goding, and U. Yavuzer DNA damage-dependent interaction of the nuclear matrix protein C1D with translin-associated factor X (TRAX) J. Cell Sci., January 1, 2002; 115(1): 207 - 216. [Abstract] [Full Text] [PDF]
|
|
